Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Su-Fern Tan, Jennifer M. Pearson, David J. Feith & Thomas P. Loughran$suffix/text()$suffix/text(). (2017) The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia. Expert Opinion on Therapeutic Targets 21:6, pages 583-590.
Read now
Read now
Francesco Spina, Paolo Emilio Alessandrino, Raffaella Milani, Francesca Bonifazi, Massimo Bernardi, Roberto Luksch, Franca Fagioli, Chiara Formica & Lucia Farina. (2012) Allogeneic stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: impact of patient characteristics and timing of transplant. Leukemia & Lymphoma 53:1, pages 96-102.
Read now
Read now
Kristin Feuerlein, Emanuele Zucca & Michele Ghielmini. (2009) First-line treatment of follicular lymphoma–a patient-oriented algorithm. Leukemia & Lymphoma 50:3, pages 325-334.
Read now
Read now
Maria H. Gilleece, Rachel Pearce, David C. Linch, Marie Wilson, Keiren Towlson, Stephen Mackinnon, Michael Potter, Majid Kazmi, John G. Gribben & David I. Marks. (2008) The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study. Hematology 13:2, pages 119-127.
Read now
Read now
Anne-Pascale Bartleman, JamesB. Kirkland & Robert Jacobs. (2008) Niacin Supplementation Decreases the Incidence of Alkylation-Induced Nonlymphocytic Leukemia in Long-Evans Rats. Nutrition and Cancer 60:2, pages 251-258.
Read now
Read now
Vicent Guillem & Mar Tormo. (2008) Influence of DNA damage and repair upon the risk of treatment related leukemia. Leukemia & Lymphoma 49:2, pages 204-217.
Read now
Read now
Mayumi Mori, Masatsugu Ohta, Akira Miyata, Masaaki Higashihara, Kazuo Oshimi, Hideo Kimura, Fumiharu Yagasaki & Kazutaka Sunami. (2006) Treatment of acute myeloid leukemia patients aged more than 75 years: Results of the E-AML-01 trial of the Japanese Elderly Leukemia and Lymphoma Study Group (JELLSG). Leukemia & Lymphoma 47:10, pages 2062-2069.
Read now
Read now
DR Barnard & WG Woods. (2005) Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer – An update. Leukemia & Lymphoma 46:5, pages 651-663.
Read now
Read now
Martin Mohren, Uwe Essbach, Astrid Franke, Anne Klink, Christian Maas, Ilka Markmann, Antje F. Pelz & Kathleen Jentsch-Ullrich. (2003) Acute Myelofibrosis in a Patient with Diffuse Large Cell Non Hodgki n's Lymphoma and Renal Cancer. Leukemia & Lymphoma 44:9, pages 1603-1607.
Read now
Read now
Articles from other publishers (77)
Guendalina Zuccari, Alessia Zorzoli, Danilo Marimpietri, Chiara Brullo & Silvana Alfei. (2023) Pyrazole-Enriched Cationic Nanoparticles Induced Early- and Late-Stage Apoptosis in Neuroblastoma Cells at Sub-Micromolar Concentrations. Pharmaceuticals 16:3, pages 393.
Crossref
Crossref
Patrick J. Hensley, Zhigang Duan, Kelly Bree, Akshay Sood, Hui Zhao, Niyati Lobo, Roberto Contieri, Matthew T. Campbell, Charles C. Guo, Neema Navai, Stephen B. Williams, Colin P. Dinney & Ashish M. Kamat. (2023) Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship. Urologic Oncology: Seminars and Original Investigations 41:2, pages 108.e11-108.e17.
Crossref
Crossref
Fan Wang. (2022) Risk and outcome of second primary malignancy in patients with classical Hodgkin lymphoma. Medicine 101:48, pages e31967.
Crossref
Crossref
Cristina Veronica Trinidad Esparza, Maria J. Lizardo-Thiebaud, María Graciela Leal-Gutierrez, Beatriz Sánchez-Hernandez & Daniel Montante Montes de Oca. (2022) Monocytosis and Multiple Myeloma: treatment-related acute leukaemia?. Surgical and Experimental Pathology 5:1.
Crossref
Crossref
Yoshihiro Hatta. (2022) II. Initial Diagnosis and Outpatient Treatment in Acute Lymphoblastic Leukemia (ALL)II．急性リンパ性白血病の初期診断と外来治療. Nihon Naika Gakkai Zasshi 111:7, pages 1351-1356.
Crossref
Crossref
Maria K. Lagou, Dimitra P. Anastasiadou & George S. Karagiannis. (2022) A Proposed Link Between Acute Thymic Involution and Late Adverse Effects of Chemotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Anatolii Aleksandrovich Danilenko, S.V. Shakhtarina & N.A. Falaleeva. (2022) Acute Myeloid Leukemias After the Treatment of Classical Hodgkin’s Lymphoma: A Literature Review. Clinical oncohematology 15:4, pages 414-423.
Crossref
Crossref
Jaison Jeevanandam, Sharadwata Pan & Michael K. Danquah. 2022. Bioprospecting of Microbial Diversity. Bioprospecting of Microbial Diversity
441
453
.
Gunhild von Amsberg & Carsten Bokemeyer. 2020. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
1
10
.
Sebastian Zahnreich & Heinz Schmidberger. (2021) Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies. Cancers 13:11, pages 2607.
Crossref
Crossref
Donald J. AbrahamWilliam A. Denny. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
74
.
Ashley Manning & Bronwen E. Shaw. 2021. Blood and Marrow Transplant Handbook. Blood and Marrow Transplant Handbook
701
710
.
Sharon Koorse Germans, Ozlem Kulak, Prasad Koduru, Dwight Oliver, Jeffery Gagan, Prapti Patel, Larry D AndersonJrJr, Franklin S Fuda, Weina Chen & Jesse Manuel Jaso. (2020) Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma—A Unique Entity. American Journal of Clinical Pathology 154:6, pages 816-827.
Crossref
Crossref
Silvana Alfei, Barbara Marengo, Guendalina Zuccari, Federica Turrini & Cinzia Domenicotti. (2020) Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells. Nanomaterials 10:6, pages 1243.
Crossref
Crossref
Olga Moser, Martin Zimmermann, Ulrike Meyer, Wolfram Klapper, Ilske Oschlies, Martin Schrappe, Andishe Attarbaschi, Georg Mann, Felix Niggli, Claudia Spix, Udo Kontny, Thomas Klingebiel, Alfred Reiter, Birgit Burkhardt & Wilhelm Woessmann. (2020) Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group. Haematologica 106:5, pages 1390-1400.
Crossref
Crossref
Daria Gaut, Anthony Bejjani, Joshua Sasine & Gary Schiller. (2019) B-Cell Acute Lymphoblastic Leukemia as a Secondary Malignancy Following Diffuse Large B-Cell Lymphoma. Hematology Reports 11:2, pages 8100.
Crossref
Crossref
Tonglin Hu, Jianping Shen, Wenbin Liu & Zhiying Zheng. (2019) Multiple myeloma secondary to acute lymphoblastic leukemia. Medicine 98:1, pages e14018.
Crossref
Crossref
Li Tao, Christina A. Clarke, Aaron S. Rosenberg, Ranjana H. Advani, Brian A. Jonas, Christopher R. Flowers & Theresa H. M. Keegan. (2017) Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era. British Journal of Haematology 178:1, pages 72-80.
Crossref
Crossref
Ossama M. Maher, Jorge Galvez Silva, Jimin Wu, Diane Liu, Laurence J.N. Cooper, Nidale Tarek, Laura Worth, Dean A. Lee, Demetrios Petropoulos, Anna R.K. Franklin, Patrick Zweidler-Mckay, Robert J. Wells, Gabriela Rondon, Richard E. Champlin & Priti Tewari. (2017) Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experience. Pediatric Transplantation 21:3, pages e12890.
Crossref
Crossref
Zachary D. Nagel, Gaspar J. Kitange, Shiv K. Gupta, Brian A. Joughin, Isaac A. Chaim, Patrizia Mazzucato, Douglas A. Lauffenburger, Jann N. Sarkaria & Leona D. Samson. (2017) DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme. Cancer Research 77:1, pages 198-206.
Crossref
Crossref
Renata Colla, Alberto Izzotti, Chiara De Ciucis, Daniela Fenoglio, Silvia Ravera, Andrea Speciale, Roberta Ricciarelli, Anna Lisa Furfaro, Alessandra Pulliero, Mario Passalacqua, Nicola Traverso, Maria Adelaide Pronzato, Cinzia Domenicotti & Barbara Marengo. (2016) Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma. Oncotarget 7:43, pages 70715-70737.
Crossref
Crossref
M. Hoffmann & P. Sharma. (2016) Inherited Mutations in Cancer Susceptibility Genes Are Common Among Survivors of Breast Cancer Who Develop Therapy-Related Leukemia. Breast Diseases: A Year Book Quarterly 27:4, pages 323-325.
Crossref
Crossref
Marko Lucijanic, Ruzica Lasan-Trcic, Rajko Kusec, Vlatko Pejsa, Tajana Stoos-Veic & Ozren Jaksic. (2015) Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia. Annals of Hematology 94:9, pages 1617-1619.
Crossref
Crossref
Ashley Manning. 2015. Blood and Marrow Transplant Handbook. Blood and Marrow Transplant Handbook
375
382
.
David A. Eastmond, Nagalakshmi Keshava & Babasaheb Sonawane. (2014) Lymphohematopoietic cancers induced by chemicals and other agents and their implications for risk evaluation: An overview. Mutation Research/Reviews in Mutation Research 761, pages 40-64.
Crossref
Crossref
Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp, Jeremy Franklin, Karolin Behringer, Teresa Halbsguth, Beate Klimm, Volker Diehl, Stephanie Sasse, Achim Rothe, Michael Fuchs, Boris Böll, Bastian von Tresckow, Peter Borchmann & Andreas Engert. (2014) Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood 123:11, pages 1658-1664.
Crossref
Crossref
Michael Byrne, Justin Wray, Brian Reinert, Yuehan Wu, Jac Nickoloff, Suk-Hee Lee, Robert Hromas & Elizabeth Williamson. (2014) Mechanisms of oncogenic chromosomal translocations. Annals of the New York Academy of Sciences 1310:1, pages 89-97.
Crossref
Crossref
Rit Vatsyayan, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, Sanjay Awasthi & Sharad S. Singhal. (2011) Nutlin‐3 enhances sorafenib efficacy in renal cell carcinoma. Molecular Carcinogenesis 52:1, pages 39-48.
Crossref
Crossref
Dana Litvak-Greenfeld & Itai Benhar. (2012) Risks and untoward toxicities of antibody-based immunoconjugates. Advanced Drug Delivery Reviews 64:15, pages 1782-1799.
Crossref
Crossref
Mihaela Onciu & Ching-Hon Pui. 2013. Childhood Leukemias. Childhood Leukemias
21
48
.
Sa A. Wang. 2011. Diagnostic Pediatric Hematopathology. Diagnostic Pediatric Hematopathology
253
271
.
Patrick Cahan & Timothy A Graubert. (2010) Integrated genomics of susceptibility to alkylator-induced leukemia in mice. BMC Genomics 11:1.
Crossref
Crossref
Ryan Mattison, Sarah Larson & Wendy Stock. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies
43
67
.
Chandra M. Das, Peter E. Zage, Pete Taylor, Dolly Aguilera, Johannes E.A. Wolff, Dean Lee & Vidya Gopalakrishnan. (2010) Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines. European Journal of Cancer 46:15, pages 2771-2780.
Crossref
Crossref
Donald J. AbrahamWilliam A. Denny. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
83
150
.
Yoshiko Nakagawa, Katsuhiro Miura, Tetsuo Yamazaki, Hikaru Ishizuka, Kazuhiro Takei, Umihiko Sawada, Yoshimasa Kura, Yoshihiro Hatta & Jin Takeuchi. (2010) A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance. International Journal of Hematology 91:3, pages 530-533.
Crossref
Crossref
Robert B. Rebhun & Douglas H. Thamm. (2010) Multiple Distinct Malignancies in Dogs: 53 Cases. Journal of the American Animal Hospital Association 46:1, pages 20-30.
Crossref
Crossref
Karina Sugita, Yoshihiro Hatta, Katsuhiro Miura, Daisuke Kurita, Yujin Kobayashi, Toshitake Tanaka, Hikari Ishizuka, Kazuhiro Takei, Sumiko Kobayashi, Shin Aizawa, Masahiko Sugitani & Jin Takeuchi. (2010) Development of Acute Monocytic Leukemia in a Patient after Chemotherapy for non-Hodgkin's Lymphoma. Journal of Nihon University Medical Association 69:3, pages 193-197.
Crossref
Crossref
Chien-Wen Chen, Kuan-Yu Chen, Chin-Jung Lin, Wann-Cherng Perng & Jia-Hong Chen. (2010) Carcinosarcoma of the pleura and lung metastasized from a poorly differentiated squamous cell carcinoma of the esophagus. Hematology/Oncology and Stem Cell Therapy 3:1, pages 47-50.
Crossref
Crossref
Marcela Stuardo, Milka Martinez, Karla Hidalgo, Martin Montecino, Amjad Javed, Jane B. Lian, Gary S. Stein, Janet L. Stein & Soraya E. Gutiérrez. (2009)
Altered chromatin modifications in
AML1/RUNX1
breakpoint regions involved in (8;21) translocation
. Journal of Cellular Physiology 218:2, pages 343-349.
Crossref
Crossref
Omari J. Bandele & Neil Osheroff. (2008) The Efficacy of Topoisomerase II-Targeted Anticancer Agents Reflects the Persistence of Drug-Induced Cleavage Complexes in Cells. Biochemistry 47:45, pages 11900-11908.
Crossref
Crossref
Ryan K. FunkTaylor J. Maxwell, Masayo IzumiDeepa EdwinFriederike Kreisel, Timothy J. LeyJames M. Cheverud & Timothy A. Graubert. (2008) Quantitative trait loci associated with susceptibility to therapy-related acute murine promyelocytic leukemia in hCG-PML/RARA transgenic mice. Blood 112:4, pages 1434-1442.
Crossref
Crossref
Peter E. Zage, Aaron J. Reitman, Roopa Seshadri, Joanna L. Weinstein, Marilyn B. Mets, Janice Lasky Zeid, Mark J. Greenwald, Lewis C. Strauss & Stewart Goldman. (2008) Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma. Pediatric Blood & Cancer 50:3, pages 567-572.
Crossref
Crossref
S. Yeasmin, K. Nakayama, M. Ishibashi, A. Oride, A. Katagiri, I. N. Purwana, K. Iida, N. Nakayama, H Ishikura & K. Miyazaki. (2008) Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review. International Journal of Gynecologic Cancer 18:6, pages 1371-1376.
Crossref
Crossref
Ida Casorelli, Elvira Pelosi, Mauro Biffoni, Anna Maria Cerio, Cesare Peschle, Ugo Testa & Margherita Bignami. (2007) Methylation damage response in hematopoietic progenitor cells. DNA Repair 6:8, pages 1170-1178.
Crossref
Crossref
Ursula R. Sorg, Veronika Kleff, Sepideh Fanaei, Alexandra Schumann, Michael Moellmann, Bertram Opalka, Jürgen Thomale & Thomas Moritz. (2007) O6-methylguanine-DNA-methyltransferase (MGMT) gene therapy targeting haematopoietic stem cells: Studies addressing safety issues. DNA Repair 6:8, pages 1197-1209.
Crossref
Crossref
Elpis Mantadakis, Vassiliki Danilatou, Eftichia Stiakaki, George Paterakis, Stefanos Papadhimitriou & Maria Kalmanti. (2007) T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia. Pediatric Blood & Cancer 48:3, pages 354-357.
Crossref
Crossref
I Casorelli, E Tenedini, E Tagliafico, M F Blasi, A Giuliani, M Crescenzi, E Pelosi, U Testa, C Peschle, L Mele, D Diverio, M Breccia, F Lo-Coco, S Ferrari & M Bignami. (2006) Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: focus on DNA repair genes. Leukemia 20:11, pages 1978-1988.
Crossref
Crossref
Wataru Aizu, Glenn S. Belinsky, Christopher Flynn, Emily J. Noonan, Colleen C. Boes, Cassandra A. Godman, Bindi Doshi, Prashant R. Nambiar, Daniel W. Rosenberg & Charles Giardina. (2006) Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors. Biochemical Pharmacology 72:8, pages 981-991.
Crossref
Crossref
Olga N. Umanskaya, Svetlana S. Lebedeva, Alexey A. Gavrilov, Andrey A. Bystritskiy & Sergey V. Razin. (2006) Inhibition of DNA topoisomerase II may trigger illegitimate recombination in living cells: Experiments with a model system. Journal of Cellular Biochemistry 99:2, pages 598-608.
Crossref
Crossref
Eric KnocheHoward L McLeodTimothy A Graubert. (2006) Pharmacogenetics of alkylator-associated acute myeloid leukemia. Pharmacogenomics 7:5, pages 719-729.
Crossref
Crossref
Ahmet Ifran, Oral Nevruz, Ferit Avcu, Şefik Güran & Ali Uğur Ural. (2006) Development of secondary myelodysplastic syndrome in a patient with previous bladder carcinoma. American Journal of Hematology 81:7, pages 560-560.
Crossref
Crossref
Mihaela Onciu & Ching-Hon Pui. 2010. Childhood Leukemias. Childhood Leukemias
21
47
.
H.T. SEE, D.A. THOMAS, C. BUESO-RAMOS & J. KAVANAGH. (2006) Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer. International Journal of Gynecological Cancer 16:S1, pages 236-240.
Crossref
Crossref
C I Chen, S Nanji, A Prabhu, R Beheshti, Q-L Yi, D Sutton & A K Stewart. (2005) Sequential, cycling maintenance therapy for post transplant multiple myeloma. Bone Marrow Transplantation 37:1, pages 89-94.
Crossref
Crossref
M V Blagosklonny. (2005) Carcinogenesis, cancer therapy and chemoprevention. Cell Death & Differentiation 12:6, pages 592-602.
Crossref
Crossref
R. Hunter Lindsey, Ryan P. Bender & Neil Osheroff. (2005) Stimulation of topoisomerase II-mediated DNA cleavage by benzene metabolites. Chemico-Biological Interactions 153-154, pages 197-205.
Crossref
Crossref
L G Lau, L K Tan, E S C Koay & T C Liu. (2004) Acute lymphoblastic leukemia after tandem autologous stem cell transplantations for multiple myeloma. Leukemia 19:2, pages 299-301.
Crossref
Crossref
Roger S. Riley, Michael Idowu, Alden Chesney, Shawn Zhao, John McCarty, Lawrence S. Lamb & Jonathan M. Ben‐Ezra. (2005) Hematologic aspects of myeloablative therapy and bone marrow transplantation. Journal of Clinical Laboratory Analysis 19:2, pages 47-79.
Crossref
Crossref
Luiz Fernando Lopes, Fábio De Simone Piccoli, Valéria A. Paixão, Maria do Rosário D.O. Latorre, Beatriz de Camargo, Andrew JG. Simpson & Otávia L. Caballero. (2004) Association of CYP3A4 genotype with detection of Vγ/Jβ trans-rearrangements in the peripheral blood leukocytes of pediatric cancer patients undergoing chemotherapy for ALL. Leukemia Research 28:12, pages 1281-1286.
Crossref
Crossref
Nuhad K. Ibrahim. (2004) Leukemogenic effect of chemotherapy in patients with breast carcinoma. Cancer 101:7, pages 1479-1481.
Crossref
Crossref
Aya Ogami, Akira Morimoto, Shigeyoshi Hibi, Shinjiro Todo, Tohru Sugimoto, Kanako Mori, Toshihiko Imamura, Hiroyuki Ishida, Takao Yoshihara, Akihiro Iguchi, Masue Imaizumi & Shinsaku Imashuku. (2004) Secondary Acute Promyelocytic Leukemia Following Chemotherapy for Non-Hodgkinʼs Lymphoma in a Child. Journal of Pediatric Hematology/Oncology 26:7, pages 427-430.
Crossref
Crossref
. 2004. Multiple Myeloma and Related Disorders. Multiple Myeloma and Related Disorders
220
240
.
Shigeo HORIIKE. (2004) Double Therapy-related Leukemia: Coincidental Occurrence or Susceptibility for Leukemia?. Internal Medicine 43:7, pages 531-532.
Crossref
Crossref
. 2004. Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach - Volume I: Principles and Methods of Immunotoxicology. Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach - Volume I: Principles and Methods of Immunotoxicology
55
126
.
GWEN L. NICHOLS. 2004. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine
629
636
.
Lawrence D. Petz & George Garratty. 2004. Immune Hemolytic Anemias. Immune Hemolytic Anemias
401
458
.
Christian Streffer, H. Bolt, D. Føllesdal, P. Hall, J. G. Hengstler, P. Jakob, D. Oughton, K. Prieß, E. Rehbinder & E. SwatonChristian Streffer, H. Bolt, D. Føllesdal, P. Hall, J. G. Hengstler, P. Jakob, D. Oughton, K. Prieß, E. Rehbinder & E. Swaton. 2004. Low Dose Exposures in the Environment. Low Dose Exposures in the Environment
83
180
.
Sister Mary Andrew Matesich & Charles L Shapiro. (2003) Second cancers after breast cancer treatment. Seminars in Oncology 30:6, pages 740-748.
Crossref
Crossref
M Bignami, I Casorelli & P Karran. (2003) Mismatch repair and response to DNA-damaging antitumour therapies. European Journal of Cancer 39:15, pages 2142-2149.
Crossref
Crossref
Thomas Lehrnbecher, Frank Deinlein, Alexander Marx & Joachim K?hl. (2003) Mediastinal T-Cell Lymphoma in a Boy 7 Years After Treatment of Supratentorial Primitive Neuroectodermal Tumor. Journal of Pediatric Hematology/Oncology 25:8, pages 657-659.
Crossref
Crossref
Leonidas G Koniaris, George Drugas, Philip J Katzman & Rabih Salloum. (2003) Management of gastrointestinal lymphoma. Journal of the American College of Surgeons 197:1, pages 127-141.
Crossref
Crossref
Kazuya Tsuboi, Hirokazu Komatsu, Hiroshi Miwa, Shinsuke Iida, Shougo Banno, Atsushi Wakita, Masakazu Nitta & Ryuzo Ueda. (2018) T-Cell Acute Lymphoblastic Leukemia as a Secondary Leukemia after a 3-Year Remission of Acute Myelocytic Leukemia. International Journal of Hematology 77:5, pages 518-521.
Crossref
Crossref
Donald J. AbrahamWilliam A. Denny. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
51
105
.
Theo de Witte, Margriet Oosterveld, Bart Span, Petra Muus & Anton Schattenberg. (2002)
S
TEM
C
ELL
T
RANSPLANTATION
FOR
L
EUKEMIAS
F
OLLOWING
M
YELODYSPLASTIC
S
YNDROMES
OR
S
ECONDARY
TO
C
YTOTOXIC
T
HERAPY
. Reviews in Clinical and Experimental Hematology 6:1, pages 72-85.
Crossref
Crossref
Mark S. KaminskiAndrew D. ZelenetzOliver W. PressMansoor SalehJohn LeonardLouis FehrenbacherT. Andrew ListerRobert J. StaggGeorge F. TidmarshStew KrollRichard L. WahlSusan J. KnoxJulie M. Vose. (2001) Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas. Journal of Clinical Oncology 19:19, pages 3918-3928.
Crossref
Crossref
. (2002) Current Awareness. Pharmacoepidemiology and Drug Safety 10:6, pages 561-576.
Crossref
Crossref